PRINCETON, N.J.--(BUSINESS WIRE)--Feb. 13, 2006--Advaxis Inc (OTCBB: ADXS) is pleased to announce that Anu Wallecha, Ph.D has joined the scientific development team, and will be responsible for the advancement and development of the Lovaxin family of vaccines. Dr. Wallecha will work under the direction of Dr. Vafa Shahabi, Director of Research and Development, at the Advaxis laboratories in North Brunswick, New Jersey. Dr. Wallecha’s vast experience with the Listeria system affords Advaxis the ability to both rapidly advance existing targets as well as develop yet unannounced clinical targets. Dr. Wallecha’s expertise also expands Advaxis’ ability to collaborate with potential partners.
